您的位置: 首页 > 农业专利 > 详情页

INTRANASAL ADMINISTRATION
专利权人:
OPTINOSE AS
发明人:
DJUPESLAND, Per Gisle,MAHMOUD, Ramy A,ANDREASSEN, Ole A,WESTLYE, Lars T,QUINTANA, Daniel S,SMERUD, Knut T,SHELDRAKE, Colin David
申请号:
SG11201703792X
公开号:
SG11201703792XA
申请日:
2015.11.19
申请国别(地区):
SG
年份:
2017
代理人:
摘要:
A delivery device for and method of modulating a condition relating to sodal cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising: providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 24 IU of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充